Search

everythinglearnresearchcommunity

for

Search:↓

Type I interferons play a key role in the development of various skin diseases.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Belimumab effectively controls SLE disease activity and reduces steroid use.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Trichoscopy is a non-invasive way to diagnose hair and scalp problems without needing hair samples.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Dupilumab helps children with alopecia areata regrow hair safely.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

CD2 might be a new treatment target for patchy alopecia areata.

iNOS contributes to hair loss in obese diabetic mice and blocking it may encourage hair growth.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

The document concludes that autoimmune skin disorders are treated with corticosteroids and immunosuppressive drugs.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.